Day One Biopharmaceuticals, Inc.
Brisbane, CA
- UEI
- G9SZJB5MEHR3
- CAGE
- 9W5Q5
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1800 Sierra Point Pkwy #200, Brisbane, CA 94005, USA
- Website
- dayonebio.com
- Founded
- 2018
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $25,906 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tovorafenib 100MG tab, PKT,1X6 ojemda | Veterans Integrated Service Network 8 (VHA) | $25,906 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Soleno Therapeutics Inc. | Redwood City, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Ionis Pharmaceuticals, Inc. | Carlsbad, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Day One Biopharmaceuticals, Inc. is a for-profit corporate entity registered in the System for Award Management (SAM.gov), headquartered in Brisbane, California. The company appears to be a biopharmaceutical organization focused on developing and supplying pharmaceutical products, with a specific emphasis on drugs and hematology-related medical treatments. Its primary federal contract work centers on providing pharmaceutical products, particularly a medication called OJEMDA, to various federal healthcare agencies, primarily within the Department of Veterans Affairs.
Through its federal contract awards, Day One Biopharmaceuticals, Inc. has demonstrated capabilities in supplying specialized pharmaceutical products, specifically TOVORAFENIB 100MG tablets and OJEMDA. The company has been awarded federal contracts and contract vehicles without any specific set-aside designations, indicating open competition for its pharmaceutical offerings. Its contract awards have been primarily issued by the Veterans Integrated Service Network (VISN) 8 and VISN 12, focusing on delivering drugs, pharmaceuticals, and hematology-related products to federal healthcare systems. The contract values range from $25,000 to $15,000,000, suggesting the company can handle diverse procurement scales for medical products.
Day One Biopharmaceuticals, Inc. holds multiple Federal Supply Schedule (FSS) contract IDVs, including a multiple-award FSS contract under Category 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. These IDVs have varying performance periods, with the longest extending to December 6, 2029, and ceiling values up to $15,000,000. The company also possesses a Blanket Purchase Agreement (BPA) awarded by the National Acquisition Center, which allows for recurring product procurement without re-competing each individual purchase. These contract vehicles enable federal agencies, particularly within the Veterans Affairs system, to efficiently procure pharmaceutical products through established pricing and terms, demonstrating the company's strategic positioning in federal healthcare product supply chains.
Quick answers
Is Day One Biopharmaceuticals, Inc. registered in SAM.gov?
Yes. Day One Biopharmaceuticals, Inc.'s SAM.gov registration is active through January 15, 2027.
What is Day One Biopharmaceuticals, Inc.'s CAGE code?
Day One Biopharmaceuticals, Inc.'s CAGE code is 9W5Q5, and its Unique Entity ID (UEI) is G9SZJB5MEHR3.
Which contract vehicles does Day One Biopharmaceuticals, Inc. hold?
Day One Biopharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Day One Biopharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $25,906 to Day One Biopharmaceuticals, Inc. in fiscal year 2025.
What is Day One Biopharmaceuticals, Inc.'s most recent federal award?
Day One Biopharmaceuticals, Inc.'s most recent federal contract award is Tovorafenib 100MG tab, PKT,1X6 ojemda (36C24825F0115), from Veterans Integrated Service Network 8 (VHA), on February 27, 2025.
On GovTribe
See Day One Biopharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors